Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 4 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 5 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.

UAA 2019 wraps up on a successful note

Pank Jit Sin
03 Sep 2019

The 17th Urological Association of Asia Congress (UAA 2019) took place from 7 to 10 August. Held at the Kuala Lumpur Convention Centre, the conference saw participation from healthcare practitioners involved in urological care from around the world.

Dato’ Dr Rohan Malek, chairman of the UAA 2019 organizing committee, said the congress received close to 1,700 attendees. Of this number, more than 1,000 were foreign participants. He described the participation as “better than expected.”

Rohan said everything went according to plan. “There were some minor audio-video hiccups here and there but on the whole, everything went smoothly. The opening ceremony, plenary lectures, and social events were well attended. We had several complimentary feedbacks from our overseas delegates and speakers, who were pleasantly surprised with the depth of the scientific programme and efficiency of the organization.”

The key takeaway garnered from the conference was emphasis on the unity amongst Asian urologists. This encompasses better collaboration, sharing of knowledge and expertise; and reaching out to the less developed countries. Additionally, the conference served to update the fraternity with the latest knowledge and technological advancements.

The congress’ deputy chairman, Dato’ Dr Selvalingam Sothilingam, said he hopes for the congress to serve as a launching pad for increased collaboration among Asian countries, and to increase research coming from Asia in the field of urology. He also hoped the congress will encourage increased utilization of robot-assisted surgery in Asia.

In parting, Rohan hopes the participants gained useful knowledge and practices that will improve urological care in Asia. He said: “[We hope the participants] enjoyed our warm hospitality and hope they cherished the time spent here in Kuala Lumpur.”

The next UAA will take place in Seoul, South Korea in October 2020.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 4 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 5 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.